ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE turns down AZ’ Daxas for COPD
pharmatimes
February 13, 2017The National Institute for Health and Care Excellence has rejected AstraZeneca's Daxas for use by the NHS to treat certain patients with chronic obstructive pulmonary disease (COPD).
Pharma Sources Insight January 2025
